Market Overview:
The global oral drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in oral drug delivery devices.
Product Definition:
Oral Drug Delivery is the process of administering a drug to a patient through their mouth. Oral drug delivery is important because it allows drugs to be absorbed directly into the bloodstream, which can improve the effectiveness of the drug.
Diffusion Controlled Release System:
The Diffusion Controlled Release System (DCR) is a novel drug delivery system which was developed to overcome the limitations of traditional controlled release systems. The advantages of DCR include extended plasma levels of drugs, sustained release over a long period, and improved pharmacokinetics & pharmacodynamics.
The global market for oral drug delivery was valued at USD 485 million in 2014.
Dissolution Controlled Release System:
A dissolution controlled release system is a method of drug delivery, which controls the rate and extent of drug release from dosage forms. The purpose is to prevent fluctuations in plasma levels caused by rapid or premature disintegration/dissolution of a drug. In order for this process to be effective, there are certain requirements such as high solubility (around 99% concentration), low molecular weight (around 1% - 5%), and pH range 3-7.
Application Insights:
Based on application, the global oral drug delivery market is segmented into hospitals, clinics and other. The other application segment includes long-term care facilities and home healthcare settings. Hospitals held the largest share in 2017 owing to factors such as high patient admissions rates due to chronic diseases and emergency cases that require immediate medical attention.
The clinics segment is expected to grow at a significant rate over the forecast period owing to increasing demand for OPD services by patients who have been diagnosed with a particular disease or condition but are looking for alternative treatment options outside of hospitals or clinical centers. These types of services are provided by walk-in clinics where patients can receive medical advice regarding their health conditions without an appointment from doctors specialized in that type of medicine along with convenient access to medications through these outpatient facilities.
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of a large number of key players and availability of advanced technologies. Moreover, growing geriatric population and increasing prevalence of chronic diseases are expected to drive the regional market over the forecast period. Asia Pacific is projected to be one of fastest-growing regions due to high unmet clinical needs coupled with rising healthcare expenditure & awareness levels regarding oral drug delivery systems among patients. Furthermore, improving healthcare infrastructure in this region will also boost growth during the forecast period. The introduction and development programs for new products by major companies also contribute towards regional growth. For instance, GlaxoSmithKline has introduced its new product line ‘Orabloc’ which comprises three different formulations namely Orabloc TS, Oralair DX and Oralair ES that are designed for rapid absorption through various routes such as oral route or enterically coated tablets & capsules thus making it suitable for treatment of HIV infection (Asia Pacific).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Oral drug delivery offers an efficient and convenient way to administer drugs to patients suffering from chronic diseases. This is likely to drive the growth of the oral drug delivery market in the coming years.
- Growing demand for targeted therapies: Oral drug delivery offers a more targeted way to administer drugs as compared to other forms such as injections or intravenous drips. This is because oral drugs can be absorbed directly into the bloodstream, thereby delivering the medication exactly where it needs to go without any wastage or side effects. As a result, there is growing demand for oral drug delivery systems for targeted therapies, which will drive market growth in this segment in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Drug Delivery Market Research Report
By Type
Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System
By Application
Hospitals, Clinics, Other
By Companies
AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Oral Drug Delivery Market Report Segments:
The global Oral Drug Delivery market is segmented on the basis of:
Types
Diffusion Controlled Release System, Dissolution Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc.
- Mylan N.V.
- Sanofi
- F. Hoffman-La-Roche Ltd.
- Bristol-Myers Squibb Company
- Sun Pharmaceuticals Industries Ltd
- Abbott Laboratories
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Vectura Group plc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc
Highlights of The Oral Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diffusion Controlled Release System
- Dissolution Controlled Release System
- Ion Exchange Resins Controlled Release
- Hydro-dynamically Balanced Drug Delivery System
- Osmotically Controlled Release System
- Dissolution & Diffusion Controlled Release System
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral drug delivery is a method of delivering medications to the mouth. It involves placing the medication in a small container, such as a pill or capsule, and giving it to the patient orally.
Some of the key players operating in the oral drug delivery market are AstraZeneca Plc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc., Novartis AG, Pfizer Inc., Vectura Group plc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc.
The oral drug delivery market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Drug Delivery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Drug Delivery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Drug Delivery Market - Supply Chain
4.5. Global Oral Drug Delivery Market Forecast
4.5.1. Oral Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Drug Delivery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Drug Delivery Market Absolute $ Opportunity
5. Global Oral Drug Delivery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Drug Delivery Market Size and Volume Forecast by Type
5.3.1. Diffusion Controlled Release System
5.3.2. Dissolution Controlled Release System
5.3.3. Ion Exchange Resins Controlled Release
5.3.4. Hydro-dynamically Balanced Drug Delivery System
5.3.5. Osmotically Controlled Release System
5.3.6. Dissolution & Diffusion Controlled Release System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Drug Delivery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Drug Delivery Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Drug Delivery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Drug Delivery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Drug Delivery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Drug Delivery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Drug Delivery Demand Share Forecast, 2019-2026
9. North America Oral Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Drug Delivery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Drug Delivery Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Drug Delivery Market Size and Volume Forecast by Type
9.7.1. Diffusion Controlled Release System
9.7.2. Dissolution Controlled Release System
9.7.3. Ion Exchange Resins Controlled Release
9.7.4. Hydro-dynamically Balanced Drug Delivery System
9.7.5. Osmotically Controlled Release System
9.7.6. Dissolution & Diffusion Controlled Release System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Drug Delivery Demand Share Forecast, 2019-2026
10. Latin America Oral Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Drug Delivery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Drug Delivery Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Drug Delivery Market Size and Volume Forecast by Type
10.7.1. Diffusion Controlled Release System
10.7.2. Dissolution Controlled Release System
10.7.3. Ion Exchange Resins Controlled Release
10.7.4. Hydro-dynamically Balanced Drug Delivery System
10.7.5. Osmotically Controlled Release System
10.7.6. Dissolution & Diffusion Controlled Release System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Drug Delivery Demand Share Forecast, 2019-2026
11. Europe Oral Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Drug Delivery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Drug Delivery Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Drug Delivery Market Size and Volume Forecast by Type
11.7.1. Diffusion Controlled Release System
11.7.2. Dissolution Controlled Release System
11.7.3. Ion Exchange Resins Controlled Release
11.7.4. Hydro-dynamically Balanced Drug Delivery System
11.7.5. Osmotically Controlled Release System
11.7.6. Dissolution & Diffusion Controlled Release System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Drug Delivery Demand Share, 2019-2026
12. Asia Pacific Oral Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Drug Delivery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Drug Delivery Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Drug Delivery Market Size and Volume Forecast by Type
12.7.1. Diffusion Controlled Release System
12.7.2. Dissolution Controlled Release System
12.7.3. Ion Exchange Resins Controlled Release
12.7.4. Hydro-dynamically Balanced Drug Delivery System
12.7.5. Osmotically Controlled Release System
12.7.6. Dissolution & Diffusion Controlled Release System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Drug Delivery Demand Share, 2019-2026
13. Middle East & Africa Oral Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Drug Delivery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Drug Delivery Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Drug Delivery Market Size and Volume Forecast by Type
13.7.1. Diffusion Controlled Release System
13.7.2. Dissolution Controlled Release System
13.7.3. Ion Exchange Resins Controlled Release
13.7.4. Hydro-dynamically Balanced Drug Delivery System
13.7.5. Osmotically Controlled Release System
13.7.6. Dissolution & Diffusion Controlled Release System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Drug Delivery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Drug Delivery Market: Market Share Analysis
14.2. Oral Drug Delivery Distributors and Customers
14.3. Oral Drug Delivery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca Plc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan N.V.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. F. Hoffman-La-Roche Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bristol-Myers Squibb Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sun Pharmaceuticals Industries Ltd
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merck & Co. Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vectura Group plc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GlaxoSmithKline plc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Johnson & Johnson Services, Inc
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook